# BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
> **ANDA217511** · Abbreviated New Drug Application (Generic) · Sponsor: INGENUS PHARMS LLC · Approved 2023-07-03
## Drug
- **FDA Application Number:** ANDA217511
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
- **Generic name:** BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE
- **Active ingredients:** BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INGENUS PHARMS LLC
- **Manufacturer:** Ingenus Pharmaceuticals, LLC
- **First approval:** 2023-07-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217511)
---
*MORVS · CC0 1.0*